RiverVest Venture Management, LLC Company Profile

19:01 EDT 24th September 2018 | BioPortfolio

RiverVest Venture Partners is a venture capital firm investing nationwide in emerging medical device, biopharmaceutical and other healthcare venture opportunities. With a total of more than 80 years of business and professional experience, our principals have the resources, knowledge and relationships required to create world-class life sciences companies. Headquartered in St. Louis, we capitalize on our access to the Midwest Centers of Excellence in life sciences.


7733 Forsyth Boulevard, Suite 1650
St. Louis
United States of America


Phone: 314.726.6700
Fax: 314.726.6715

News Articles [500 Associated News Articles listed on BioPortfolio]

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partners and included investments by first-time buyers Qatar Investment Authority...

OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies

Houston—OncoResponse, a Seattle biotech startup formed jointly with the University of Texas M.D. Anderson Cancer Center in Houston, announced Tuesday it has raised a $40 million Series B round o...

Immunotherapy firm OncoResponse secures $40m series B financing

Participants in the round, which was led by RiverVest Venture Partners, included new investors Qatar Investment Authority (QIA) and Redmile Group, and existing investors Alexandria Venture Investments...

OncoResponse Raises $40 Million in Series B Financing

-- Adds RiverVest Venture Partners, Qatar Investment Authority and Redmile Group to List of Financial Backers -- -- Proceeds Will Advance Growing Portfolio of Therapeutic...

Standard Bariatrics closes Series A round of financing

(CincyTech) Standard Bariatrics Inc., an innovator of bariatric surgical devices, has raised a Series A round of financing. RiverVest Venture Partners led the round. The size of the round is undisclos...

28-7 Therapeutics Raises $65 Million to Advance Tumor Suppressor Research

Twentyeight-Seven Therapeutics (28-7), announced it had completed a $65 million Series A financing. It was co-led by founding investor MPM Capital and Novartis Venture Fund. Joining them were Johnson ...

Cytrellis Biosystems completes $28.5mm Series B round

Cytrellis Biosystems Inc. (noninvasive aesthetic plastic surgery devices to reduce wrinkles and skin laxity) raised $28.5mm through a Series B round backed by returning investors Arch Venture Partners...

Cibus Raises $70M for Marketing of Gene-Edited Canola, More R&D

Sales of Cibus’ first product, a gene-edited canola, have gone so well that the San Diego company has raised $70 million in new financing to boost its commercialization efforts. The Series C round o...

PubMed Articles [1829 Associated PubMed Articles listed on BioPortfolio]

Grant Funding Needs Parallel the Start-Up Venture: An Analogy for Translational Research Success.

This editorial offers some ways to think about how best to position a research group for funding, by examining the parallels between what is needed for translational grants versus industry start-ups.

Supporting self-management in palliative care throughout the cancer care trajectory.

Despite increased survivorship and the subsequent need for chronic management of cancer, the association of self-management and palliative care is still emerging within cancer care. Routine and timely...

ICU Management of Trauma Patients.

To describe the current state of the art regarding management of the critically ill trauma patient with an emphasis on initial management in the ICU.

mHealth Applications: A Tool for Behaviour Change in Weight Management.

Obesity has become a public concern all over the world and weight management is of interest to consumers. Heavy intake of food and lack of exercise are the foremost factors for obese condition. Self-m...

Are fishery management upgrades worth the cost?

Many analyses of fishery recovery have demonstrated the potential biological and economic benefits of management reform, but few have compared these to the associated costs of management upgrades, whi...

Clinical Trials [2527 Associated Clinical Trials listed on BioPortfolio]

Quest Sound Recover (SR2) vs. Venture SR2

Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform. To investigate the improvements of this feature is compared on a new and older hearing...

Hepatitis C Self-Management

The objective of this study is to compare the efficacy of a 6-session hepatitis C self-management workshop to a hepatitis C self-management self-study program. Both interventions are desig...

Contingency Management Treatment Duration

310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatmen...

Allo - Cancer - Thrombosis

Management of venous thromboembolism (VTE) in patients with cancer is complex and require the intervention of many specialized health professionals, in hospital but also at home and during...

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagon...

Companies [2043 Associated Companies listed on BioPortfolio]

RiverVest Venture Partners

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies throughout the U.S. to create significant shareholder va...

RiverVest Venture Management, LLC

RiverVest Venture Partners is a venture capital firm investing nationwide in emerging medical device, biopharmaceutical and other healthcare venture opportunities. With a total of more than 80 years o...

Venture Verde

Venture Verde is a real estate, land and water management company and a subsidiary of BLMG Holdings, LLC (BLMG). Venture Verde consults and develops sustainable turnkey fac...

Origo Management

Origo Management provides specialized consulting services to the private equity and venture capital industry. Our clients include players from all stages of the private equity and venture capital valu...

Advent Venture Partners

Advent Venture Partners is one of the most experienced technology venture capital firms in the UK. Established in 1981 it invests in both the Information and Communications Technology and Life Science...

More Information about "RiverVest Venture Management, LLC" on BioPortfolio

We have published hundreds of RiverVest Venture Management, LLC news stories on BioPortfolio along with dozens of RiverVest Venture Management, LLC Clinical Trials and PubMed Articles about RiverVest Venture Management, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RiverVest Venture Management, LLC Companies in our database. You can also find out about relevant RiverVest Venture Management, LLC Drugs and Medications on this site too.

Quick Search


Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record